ACAM2000: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
== ACAM2000 == | |||
[[File:Smallpox_vaccination_needle.jpg|thumb|right|A bifurcated needle used for smallpox vaccination]] | |||
[[ | |||
'''ACAM2000''' is a [[smallpox vaccine]] that is used to protect against the [[variola virus]], the causative agent of [[smallpox]]. It is a live, attenuated vaccine derived from the [[vaccinia virus]], which is closely related to the variola virus. ACAM2000 is administered using a bifurcated needle, a method that is distinct from the typical intramuscular or subcutaneous injections used for many other vaccines. | |||
== | == History == | ||
The development of ACAM2000 was initiated in response to the need for a safer and more effective smallpox vaccine. The original smallpox vaccine, known as [[Dryvax]], was used during the global smallpox eradication campaign led by the [[World Health Organization]] (WHO). However, Dryvax was associated with certain adverse effects, prompting the development of ACAM2000 as a second-generation vaccine. | |||
ACAM2000 | |||
== | == Administration == | ||
== | ACAM2000 is administered using a bifurcated needle, which is dipped into the vaccine solution and then used to prick the skin multiple times in a small area, usually on the upper arm. This method creates a localized infection with the vaccinia virus, leading to the development of immunity against smallpox. The site of vaccination typically develops a pustule, which eventually scabs over and heals, leaving a small scar. | ||
ACAM2000 | |||
== Efficacy and Safety == | |||
ACAM2000 has been shown to be effective in inducing immunity against smallpox. However, as with any live vaccine, there are potential risks and side effects. Common side effects include mild fever, fatigue, and localized skin reactions. More serious complications, such as [[myocarditis]] and [[pericarditis]], have been reported, although they are rare. | |||
== Use in Biodefense == | |||
Due to the potential use of smallpox as a [[bioterrorism]] agent, ACAM2000 is stockpiled by various governments as part of their biodefense strategies. The vaccine is not used in routine immunization programs, as smallpox was declared eradicated in 1980. However, it remains an important tool for emergency preparedness. | |||
== Related Pages == | |||
* [[Smallpox]] | * [[Smallpox]] | ||
* [[Vaccinia | * [[Vaccinia virus]] | ||
* [[Bioterrorism]] | * [[Bioterrorism]] | ||
* [[World Health Organization]] | |||
[[Category:Vaccines]] | [[Category:Vaccines]] | ||
[[Category: | [[Category:Biodefense]] | ||
Latest revision as of 11:15, 15 February 2025
ACAM2000[edit]
ACAM2000 is a smallpox vaccine that is used to protect against the variola virus, the causative agent of smallpox. It is a live, attenuated vaccine derived from the vaccinia virus, which is closely related to the variola virus. ACAM2000 is administered using a bifurcated needle, a method that is distinct from the typical intramuscular or subcutaneous injections used for many other vaccines.
History[edit]
The development of ACAM2000 was initiated in response to the need for a safer and more effective smallpox vaccine. The original smallpox vaccine, known as Dryvax, was used during the global smallpox eradication campaign led by the World Health Organization (WHO). However, Dryvax was associated with certain adverse effects, prompting the development of ACAM2000 as a second-generation vaccine.
Administration[edit]
ACAM2000 is administered using a bifurcated needle, which is dipped into the vaccine solution and then used to prick the skin multiple times in a small area, usually on the upper arm. This method creates a localized infection with the vaccinia virus, leading to the development of immunity against smallpox. The site of vaccination typically develops a pustule, which eventually scabs over and heals, leaving a small scar.
Efficacy and Safety[edit]
ACAM2000 has been shown to be effective in inducing immunity against smallpox. However, as with any live vaccine, there are potential risks and side effects. Common side effects include mild fever, fatigue, and localized skin reactions. More serious complications, such as myocarditis and pericarditis, have been reported, although they are rare.
Use in Biodefense[edit]
Due to the potential use of smallpox as a bioterrorism agent, ACAM2000 is stockpiled by various governments as part of their biodefense strategies. The vaccine is not used in routine immunization programs, as smallpox was declared eradicated in 1980. However, it remains an important tool for emergency preparedness.
